beta
(영문) 서울중앙지방법원 2018.12.14 2017가단5186281

보험금

Text

1. The Defendant: (a) from August 26, 2017, to Plaintiff A with respect to KRW 20,000,000; (b) from August 26, 2017, to Plaintiff B with respect to KRW 24,00,000; and (c) it.

Reasons

1. Facts of recognition;

A. The Plaintiff’s wife A’s wife D is an insurance contract with the Defendant on December 1, 1999 (hereinafter “instant insurance contract”).

(A) The principal insured and beneficiary of the above contract are Plaintiff A and the principal insured and beneficiary of the above contract are KRW 20 million per time when the cancer diagnosis is finalized, and KRW 5 million per time when the cancer treatment purpose is performed, and in the case of upper cancer, KRW 20% of the corresponding amount is paid. The definition and diagnosis determination of cancer pursuant to Article 9 of the terms and conditions of the first insurance contract are as follows. (A) “A” refers to a disease classified as malicious Organisms from the basic classification of the Korea Standard Disease Classification (see attached Table 3).

(The main sentence of paragraph 1). [Attachment 3] of the Korea Standard Disease Death Classification Clause, the following diseases are the following diseases, among the third revised Korean Standard Disease Death Classification Clause (Enforcement Decree No. 1993-3, January 1, 1995 of the Statistics Korea Notice No. 1993-3, January 1, 1995):

The target malicious Organism Classification Number

2.After the amendment of the fourth amendment of the fire extinguishing body's malicious life C15-C26, the Korean Standard Disease Classification (hereinafter referred to as the "Korean Standard Disease Classification") shall include the disease, if there is a disease which falls under the terms and conditions other than the above diseases.

B) The confirmation of cancer diagnosis should be made by a person with a professional doctor’s license of autopsy pathology or clinical pathology based on the present opinion on tissue or blood test. However, when such pathology diagnosis is not possible, if documents or evidence proving that the insured was diagnosed or treated as cancer exist, the clinical diagnosis of cancer is recognized as evidence of cancer (Paragraph 2). (2) On December 13, 2013, Plaintiff B entered into an insurance contract with the Defendant (hereinafter “instant insurance contract”) with the F insurance (hereinafter “instant insurance contract”). The Plaintiff B paid KRW 30 million only once when the diagnosis of cancer other than largeum cancer, basin cancer, and precoption cancer becomes final and conclusive, and paid KRW 6 million only once.